Dialysis Exercise With a Bed Compatible Leg TRAiningstool (DEXTRA)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT06045442 |
Recruitment Status :
Completed
First Posted : September 21, 2023
Last Update Posted : September 22, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Chronic Kidney Diseases Hemodialysis | Behavioral: Intradialytic exercise training Behavioral: Control | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 32 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | Random assignment in 1:1 ratio to either the intervention group (intradialytic exercise; twice a week for 30 min per dialysis session) or control group (Usual care) |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Exercise During Hemodialysis With a Bed Compatible Trainingstool: a Randomized Controlled Trial |
Actual Study Start Date : | May 3, 2023 |
Actual Primary Completion Date : | August 8, 2023 |
Actual Study Completion Date : | August 8, 2023 |
![](/ct2/html/images/NIH_NLM_ABRV_BLK_4.png)
Arm | Intervention/treatment |
---|---|
Experimental: Intervention
3 months intradialytic exercise intervention: 30 minutes of endurance training at the dialysis unit with a dialysis training device, twice a week.
|
Behavioral: Intradialytic exercise training
The patients in the intervention group will receive 3 months of endurance training, 2x/week for 30 min. 5 min of this should be a warm-up, 20 min of exertion and 5 min of cool down. The warm-up and cool-down should be equivalent to a very light load (Borg scale 9), whereas the exertion phase should be exhausting for the patients (Borg scale 14-15). |
Active Comparator: Control
Usual Care
|
Behavioral: Control
Usual care |
- Sit-to-stand test (STS60) [ Time Frame: 3 month ]measured in number of repetitions in 60 seconds
- Timed-up-and-go test (TUG) [ Time Frame: 3 month ]measured in time (seconds)
- muscle mass [ Time Frame: 3 month ]measured in kg by bio-impedance analysis
- body fat mass [ Time Frame: 3 month ]measured in kg by bio-impedance analysis
- Quality of life by Kidney Disease Quality of Life Instrument (KDQOL) [ Time Frame: 3 month ]measured in change of scale by questionnaire (higher Score = better health; Questions are combined to form items and the average is calculated; Range from 0-100)
- Fatigue by Fatigue Assessment Scale (FAS) [ Time Frame: 3 month ]measured in change of scale by questionnaire (scores can range from 10 (lowest level of fatigue) to 50 (highest level of fatigue)
- activity by Freiburg Questionnaire of physical activity [ Time Frame: 3 month ]measured in change of scale by questionnaire (The higher the score, the more active the participant. the lowest level would be a score of 0)
![](/ct2/html/images/NIH_NLM_ABRV_BLK_4.png)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients ≥ 18 years
- Patients who started dialysis more than 3 months ago
- Patients must be mentally and physically able to participate in exercise
Exclusion Criteria:
- Patients who are not mentally or physically able to participate in intradialytic exercise. These include patients with uncontrolled high blood pressure and uncontrolled diabetes mellitus, diseases that impair physical performance or/and could be aggravated by activity, such as ischaemic cardiopathy or symptoms associated with coronary heart disease, chronic coronary heart disease, chronic lung disease and orthopaedic conditions that make exercise impossible.
![](/ct2/html/images/NIH_NLM_ABRV_BLK_4.png)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT06045442
Germany | |
Universitätsklinikum Erlangen | |
Erlangen, Bavaria, Germany, 91054 |
Study Director: | Mario Schiffer, Prof. | Universitätsklinikum Erlangen |
Responsible Party: | University of Erlangen-Nürnberg Medical School |
ClinicalTrials.gov Identifier: | NCT06045442 |
Other Study ID Numbers: |
23-40-B |
First Posted: | September 21, 2023 Key Record Dates |
Last Update Posted: | September 22, 2023 |
Last Verified: | September 2023 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Dialysis Intradialytic exercise Hemodialysis training |
Kidney Diseases Renal Insufficiency, Chronic Urologic Diseases Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Urogenital Diseases |
Male Urogenital Diseases Renal Insufficiency Chronic Disease Disease Attributes Pathologic Processes |